Skip to content
VuFind
  • Login
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
Advanced
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Permanent link
Cover Image

Saved in:
Bibliographic Details
Main Authors: Wang, Qingwei, Guo, Liangsheng, Wang, Shuai, Guan, Chengdan, Pan, Junhao, Zhu, Shaoping, Zheng, Lei, Wu, Xuehua, Gu, Yonghui, Shu, Tao, Luo, Lianxiang, Lai, Tianwen, Gao, Xiao
Format: Artículo científico
Language:en
Published: BMC biology 2026
Subjects:
Humans
Bromodomain Containing Proteins
Adenocarcinoma of Lung
Transcription Factors
Lung Neoplasms
LIM Domain Proteins
Cell Cycle Proteins
Cyclin-Dependent Kinase Inhibitor p21
Tumor Suppressor Protein p53
Animals
Transcriptional Activation
Cell Line, Tumor
Mice
Gene Expression Regulation, Neoplastic
Online Access:https://pubmed.ncbi.nlm.nih.gov/41546036/
Tags: Add Tag
No Tags, Be the first to tag this record!
  • Holdings
  • Description
  • Table of Contents
  • Comments
  • Similar Items
  • Staff View

Internet

https://pubmed.ncbi.nlm.nih.gov/41546036/

Similar Items

  • BIT1 as an Effector of EGFR-TKI-induced Apoptosis TLE1 Inhibition in Lung Adenocarcinoma Cells.
    by: Dela Cruz, Ma Carmela, et al.
    Published: (2026)
  • pVHL regulates protein stability of the TCF/LEF transcription factor family via ubiquitin-independent proteasomal degradation.
    by: Wang, Caixia, et al.
    Published: (2025)
  • Ultrasonication-assisted green synthesis, in silico EGFR-binding analysis, and cytotoxic evaluation of nitro-perimidines for non-small cell lung cancer.
    by: Gopinadh, Meera, et al.
    Published: (2026)
  • Ulvan derived from Ulva lactuca suppresses hepatocellular carcinoma cell proliferation through miR-542-3p-mediated downregulation of SLC35F6.
    by: Qiu, Yinghui, et al.
    Published: (2025)
  • Design, synthesis, and biological evaluation of N-(2-amino-phenyl)-5-(4-aryl- pyrimidin-2-yl) amino)-1H-indole-2-carboxamide derivatives as novel inhibitors of CDK9 and class I HDACs for cancer treatment.
    by: Chen, Xiaohui, et al.
    Published: (2025)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs